Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature-Reference-Cited by-同舟云学术

Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature

Published:2010-02-26 Issue:7 Volume:50 Page:1561-1567
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:

Author:

Donahue Laura L.,Shapira Iuliana,Shander Aryeh,Kolitz Jonathan,Allen Steven,Greenburg Gerson

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2010.02603.x/fullpdf

Reference43 articles.

1. Haemoglobin, oxygen carriers and perioperative organ perfusion;Kocian;Best Pract Res Clin Anaesthesiol,2008

2. Tissue oxygen saturation predicts the need for early blood transfusion in trauma patients;Smith;Am Surg,2008

3. Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations;Munoz;Vox Sang,2009

4. Cell salvage for minimising perioperative allogeneic blood transfusion;Carless;Cochrane Database Syst Rev,2006

5. Bloodless medicine: clinical care without allogeneic blood transfusion;Goodnough;Transfusion,2003

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Legal considerations regarding the blood transfusion refusal in cases of minor patients;Timisoara Medical Journal;2024-07-09

2. Tracking Research on Hemoglobin-Based Oxygen Carriers: A Scientometric Analysis and In-Depth Review;Drug Design, Development and Therapy;2023-08

3. Use of cell salvage and HBOC-201 in a pregnant Jehovah’s Witness with sickle beta+thalassaemia undergoing emergency caesarean section;BMJ Case Reports;2022-11

4. Use of Oxygen Therapeutics in Patients for Whom Blood Is Not an Option;Blood Substitutes and Oxygen Biotherapeutics;2022

5. HBOC-201: History, Clinical Trials, and Path Forward;Blood Substitutes and Oxygen Biotherapeutics;2022